Upgrade to SI Premium - Free Trial

Merck (MRK) Announces FDA Approval of Expanded Monotherapy Label for its KEYTRUDA

April 11, 2019 5:45 PM
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles